Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01732822 · ClinicalTrials.gov registry record · Phase 3
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
A Phase 3 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 3
- Development phase
- 13,885
- Enrollment target
NCT01732822: Completed Phase 3 study, sponsored by AstraZeneca.
NCT01732822 is a Phase 3 study that has completed, run by AstraZeneca. The registered enrollment target is 13,885 participants, above the 771-participant average among 15,282 other Phase 3 trials with a reported enrollment target (1701% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01732822, a Phase 3 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 13,885 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effects of ticagrelor and clopidogrel in patients with Peripheral Artery Disease.
Primary Outcome
Participants with CV death, myocardial infarction (MI) or ischemic stroke. If no event, censoring occurs at the minimum of (primary analysis censoring date (PACD), last endpoint assessment date, non-CV death date)
Interventions
- DRUG Clopidogrel
- DRUG Ticagrelor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13,885 participants |
| Start Date | 2012-12-04 |
| Est. Completion | 2016-09-26 |
| Phase | Phase 3 |
What the finished NCT01732822 record still lists
NCT01732822 is an interventional study that assigns participants to a tested intervention. Its 13,885 participants enrollment target places it among the larger protocols in the corpus, above the 771-participant average among 15,282 other Phase 3 trials with a reported enrollment target (1701% higher).
The record links to 0 conditions, and to 2 interventions - of which Clopidogrel is the first listed.
NCT01732822 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01732822 about?
NCT01732822 is a clinical study titled "A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease". The purpose of this study is to compare the effects of ticagrelor and clopidogrel in patients with Peripheral Artery Disease.
What is the current status of trial NCT01732822?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 13,885 participants. The study started on 2012-12-04. Estimated completion is 2016-09-26.
What interventions are being tested in trial NCT01732822?
The interventions under investigation include: Clopidogrel (DRUG), Ticagrelor (DRUG).
Who is sponsoring clinical trial NCT01732822?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01732822's enrollment target sits among peer trials
13,885 17th of 2000 higher than 1,984 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06058767 · 13,764 participants · NA
Preschool Hearing Screening
- NCT05141396 · 13,400 participants · NA
Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
- NCT05591066 · 14,400 participants · NA
The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now
- NCT05359016 · 14,600 participants · NA
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI